Table 1 Basic patient characteristics
Parameter | Median (IQR) | Minimum-maximum |
|---|---|---|
Age (years) | 24.3 (20.7;32.0) | 18.4–37.0 |
BMI (kg/m2) | 23.4 (22.0;26.6) | 20.4–30.5 |
Duration of testosterone treatment (months) | 16.8 (12.1;24.0) | 12.0–38.4 |
FSH (mU/mL) | 4.9 (2.6;6.5) | 1.2–7.6 |
LH (mU/mL) | 2.6 (1.0;10.8) | 0.0–25.8 |
Estradiol (pg/mL) | 39 (33;55) | 19–170 |
Total testosterone (ng/mL) | 5.18 (4.46;6.16) | 2.88–9.08 |
SHBG (nmol/L) | 34.1 (23.4;38.9) | 14.3–50.0 |
Bioavailable testosterone (ng/mL) | 2.69 (1.96;3.38) | 1.54–4.30 |